恶性胸腺瘤,malignant thymoma
1)malignant thymoma恶性胸腺瘤
bined chemotherapy for myasthenia gravis withmalignant thymoma;重症肌无力伴恶性胸腺瘤的联合化疗
2.Aim:To observe the clinical outcome of surgical treatment formalignant thymoma with myasthenia gravis (MG),and evaluate the prognostic factors.目的:观察恶性胸腺瘤伴重症肌无力患者的临床疗效及预后影响因素。
3.Purpose:Surgery is the primary treatment ofmalignant thymoma, and radiotherapy improves local control rate and overall survival, which make them of essential importance in treatment ofmalignant thymoma.目的:恶性胸腺瘤首选的治疗方案是手术治疗,放射治疗提高了局部肿瘤控制率及总生存,在恶性胸腺瘤的治疗中占有重要的地位。
英文短句/例句
1.Chemotherapy Efficacy and Prognostic Factors Analysis of 72 Patients with Malignant Thymoma72例恶性胸腺瘤的化疗疗效和预后因素分析
2.Surgical Treatment and Prognostic Analysis in Patients with Malignant Thymoma恶性胸腺瘤患者手术疗效及其预后因素分析
3.Surgical Management and Prognosis Analyze of Thymoma Invading the Great Vessels恶性胸腺瘤侵犯大血管的手术治疗及术后生存调查
4.Thymus Gland Transplantation Nursing Care胎儿胸腺移植治疗恶性肿瘤的护理
5.diffuse malignant mesothelioma of pleura弥漫性恶性胸膜间皮瘤
6.Treatment of advanced cancer with activat-ed fetal thymocyte and human nature IL-2--An analysis of 63 cases天然人白细胞介素-2及活化胎儿胸腺细胞治疗晚期恶性肿瘤63例
7.Significance of Pre-Operative and Post-Operative Immunoglobulin Assay in Patients with Malignant Tumor Undergone Thymus Transplantation;恶性肿瘤患者胸腺移植前后免疫球蛋白测定及临床意义
8.The improvement of chemotherapy combined with thymopetidum on cellular immunity of patients with gastrointestinal malignant tumor in the later stage胸腺肽联合化疗改善胃肠道恶性肿瘤患者的细胞免疫功能
9.CLINICAL OBSERVATION OF THYMIC PEPTIDE ASSOCIATED CONTAINING PLATINUM CHEMOTHERAPY PROJECT TREATING SENILE MALIGNANT TUMOR PATIENT胸腺肽联合含铂类化疗方案治疗老年恶性肿瘤的临床观察
10.Immunomodulatory Effect of Thymopentin on Post-Chemotherapeutic Cancer in Children胸腺五肽对恶性肿瘤患儿化疗停药后的免疫调节作用
11.malignant tumor originating in glandular epithelium.长在腺体上的恶性肿瘤。
12.A malignant tumor originating in glandular tissue.腺癌起源于腺性组织的恶性肿瘤
13.Clinical Analysis of 31 Cases with Malignant Pleural Mesothelioma;恶性胸膜间皮瘤31例临床病例分析
14.CT differential diagnosis of thoracic malignant lymphoma:part Ⅱ胸部恶性淋巴瘤的CT鉴别诊断(二)
15.Initial Exploration for the Value of Radiofrequency Ablation of Pulmonary Malignancies by VATS胸腔镜下射频消融治疗肺部恶性肿瘤
16.Successful Treatment of One Case of Malignant Pleural Mesothelioma赵远红辨治恶性胸膜间皮瘤验案1则
17.Correlation of VEGF expression and microvessel density with spiral CT manifestations of thymoma胸腺瘤中VEGF的表达及微血管密度与其胸腺瘤螺旋CT表现的相关性
18.Treatment of malignant pleural mesothelioma with pleurectomy and intraplueral infusion chemotherapy胸膜切除术加胸腔灌注化疗治疗恶性胸膜间皮瘤
相关短句/例句
Thymoma[英][θai"m?um?][美][θa?"mom?]恶性胸腺瘤
1.Clinical and Immunological Study of One Case Paraneoplastic Pemphigus Complicated withThymoma;1例伴发恶性胸腺瘤的副肿瘤性天疱疮临床及免疫学研究
3)Extrathymic malignancy胸腺外恶性肿瘤
4)malignant thymic tumor恶性胸腺肿瘤
1.Objective: To determine the effects of radiation of mediastinal tumors on radiation-induced heart disease and refine the radiotherapy approach for clinical treatment to reduce cardiac toxicity- a series of consecutive cases treated by radiotherapy formalignant thymic tumor was retrospectively studied.目的:本文回顾性研究一组连续收治行放射治疗的恶性胸腺肿瘤病例,应用剂量体积直方图分析心脏受照情况,同时结合临床随访放射性心脏损伤的结果,探讨了影响心脏损伤的因素和避免或减少心脏损伤的有效方法。
5)malignant adenoma恶性腺瘤
1.Methods With minimal deviation adenocarcinoma of cervix ormalignant adenoma of cervix as key words,we retrieved the published articles of MDA of cervix during 1980- .方法分别以子宫颈微偏腺癌和子宫颈恶性腺瘤的中、英文作为检索词,检索1980至国内外公开发表的文献,并结合我院诊治4例子宫颈MDA,进行meta分析。
6)Malignant pleural mesothelioma恶性胸膜间皮瘤
1.Efficacy and safety of pemetrexed combined with platinum complexes in the treatment of malignant pleural mesothelioma;培美曲塞联合铂类制剂治疗恶性胸膜间皮瘤的有效性与安全性
2.Diagnosis of malignant pleural mesothelioma by thoracoscopy;经电视胸腔镜确诊恶性胸膜间皮瘤
3.Curative effect of Alimta combined with platinum complexes in the treatment of 20 patients with malignant pleural mesothelioma;力比泰联合顺铂治疗30例恶性胸膜间皮瘤的疗效观察
延伸阅读
胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液药物名称：胸腺肽注射液英文名：Thymopetidum Injection别名：胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液、胸腺因子注射液、胸腺因子D注射液。性状：本品为无色或微黄色澄明液体。药理作用： 促使骨髓产生的干细胞转变为T细胞，从而增强细胞免疫功能。 从健康乳牛胸腺中提取制得的多肽类细胞免疫调节剂。可作用于T淋巴细胞分化的各个阶段，有调节和增强人体免疫功能的作用，可提高机体的防病抗病能力，缩短感染性疾病的治疗周期。用于原发或继发性免疫缺陷病或免疫功能失调引起的各种疾病、自身免疫性疾病以及病毒或细菌性感染和肿瘤的辅助治疗。适应症： 用于免疫缺陷病、恶性肿瘤及病毒性疾病。 用于治疗各种原发性或继发性T细胞缺陷病，某些自身免疫性疾病，各种细胞免疫功能低下的疾病及肿瘤的辅助治疗.用量用法： 肌注：每次2-10mg，每日或隔日1次。对于胸腺发育不全症患者应做替代治疗，每日1mg/kg，病情好转后改为维持量每周1mg/kg。 静脉滴注：一次20～80mg，溶于500ml，0.9%氯化钠注射液或5%葡萄糖注射液，一日1次或遵医嘱。注意事项：1.对于过敏体质者，注射前或治疗终止后再用药时需做皮内敏感试验（配成25μg/ml的溶液，皮内注射0.1ml），阳性反应者禁用。2.本品如出现混浊或絮状沉淀物等异常变化，禁忌使用。3. 有发热、头晕、皮疹等。规格： 注射剂：2mg/2ml；5mg/2ml。2ml:5mg;2ml：20mg类别：免疫调节剂
